Dr Brian William Patterson, MD | |
600 Highland Ave, Madison, WI 53792-0001 | |
(608) 262-2398 | |
Not Available |
Full Name | Dr Brian William Patterson |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 15 Years |
Location | 600 Highland Ave, Madison, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093944902 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 60528 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Wi Hospitals & Clinics Authority | Madison, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Wisconsin Medical Foundation Inc | 6608785464 | 2164 |
News Archive
An international research team led by Kerstin Lindblad-Toh at the Broad Institute, US and Uppsala University, Sweden has mapped and compared the genomes of 29 mammals. The findings, published in Nature, reveal millions of new regulatory elements in the human genome that in various ways govern how proteins are formed. The new knowledge is important for our understanding of how mutations in human genes give rise to diseases.
A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics.
HemaCare Corporation announced today that it has reached a definitive agreement to sell certain assets of its Blood Services operations to the American Red Cross. Under the terms of the sale, which closed today, HemaCare sold its red blood cell collection operation assets to the American Red Cross. The sale does not include HemaCare's platelet collection business.
MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
› Verified 1 days ago
Entity Name | University Of Wisconsin Medical Foundation Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
An international research team led by Kerstin Lindblad-Toh at the Broad Institute, US and Uppsala University, Sweden has mapped and compared the genomes of 29 mammals. The findings, published in Nature, reveal millions of new regulatory elements in the human genome that in various ways govern how proteins are formed. The new knowledge is important for our understanding of how mutations in human genes give rise to diseases.
A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics.
HemaCare Corporation announced today that it has reached a definitive agreement to sell certain assets of its Blood Services operations to the American Red Cross. Under the terms of the sale, which closed today, HemaCare sold its red blood cell collection operation assets to the American Red Cross. The sale does not include HemaCare's platelet collection business.
MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brian William Patterson, MD 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Dr Brian William Patterson, MD 600 Highland Ave, Madison, WI 53792-0001 Ph: (608) 262-2398 |
News Archive
An international research team led by Kerstin Lindblad-Toh at the Broad Institute, US and Uppsala University, Sweden has mapped and compared the genomes of 29 mammals. The findings, published in Nature, reveal millions of new regulatory elements in the human genome that in various ways govern how proteins are formed. The new knowledge is important for our understanding of how mutations in human genes give rise to diseases.
A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics.
HemaCare Corporation announced today that it has reached a definitive agreement to sell certain assets of its Blood Services operations to the American Red Cross. Under the terms of the sale, which closed today, HemaCare sold its red blood cell collection operation assets to the American Red Cross. The sale does not include HemaCare's platelet collection business.
MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used in research and manufacturing in the Biopharmaceutical, In vitro diagnostic and Biotech sectors.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
› Verified 1 days ago
Kendra L Fabian, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-262-2398 | |
Michael K Abernethy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-262-2398 Fax: 608-262-9999 | |
Kip A Kircher, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St Ste A404, Madison, WI 53715 Phone: 608-258-6504 | |
Dr. Joseph David Hansen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 700 S Park St, Madison, WI 53715 Phone: 800-680-4369 | |
Milton H Johnson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 752 N High Point Rd, Madison, WI 53717 Phone: 608-824-4000 Fax: 608-824-4919 | |
Dr. Jon Dirk Van Roo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Suite A404, Madison, WI 53715 Phone: 608-258-6504 | |
Dr. Aaron Kraut, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-262-2398 |